Zoetis Inc Class A (ZTS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
$161.50
Buy
$169.00
$2.26 (+1.37%)
Prices updated at 01 Mar 2025, 00:59 EST
| Prices minimum 15 mins delay
Prices in USD
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2024 | 70.62 |
2023 | 70.03 |
2022 | 69.63 |
2021 | 70.38 |
2020 | 69.18 |
2019 | 68.18 |
2018 | 67.19 |
2017 | 66.55 |
2016 | 65.92 |
Valuation data table
Year | Price / Sales |
---|---|
2025 | 8.22 |
2024 | 8.14 |
2023 | 10.94 |
2022 | 8.65 |
2021 | 15.30 |
2020 | 12.12 |
2019 | 10.39 |
2018 | 7.30 |
2017 | 6.95 |
2016 | 5.47 |
2015 | 5.01 |
Price/Forward earnings (YTD)
27.78
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2024 | 17.43 |
2023 | 16.05 |
2022 | 14.67 |
2021 | 14.81 |
2020 | 13.02 |
2019 | 13.44 |
2018 | 14.75 |
2017 | 10.64 |
2016 | 10.55 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 2.98 |
2023 | 2.86 |
2022 | 3.39 |
2021 | 3.06 |
2020 | 3.61 |
2019 | 4.26 |
2018 | 4.93 |
2017 | 4.85 |
2016 | 5.14 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.